Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED JULY 2, 2011

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM             TO             

COMMISSION FILE NUMBER: 001-11593

 

 

THE SCOTTS MIRACLE-GRO COMPANY

(Exact name of registrant as specified in its charter)

 

OHIO   31-1414921
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

14111 SCOTTSLAWN ROAD,

MARYSVILLE, OHIO

  43041
(Address of principal executive offices)   (Zip Code)

(937) 644-0011

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes   x     No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

     Yes   ¨     No   x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Class

 

Outstanding at August 4, 2011

Common Shares, $0.01 stated value, no par value   62,855,438 common shares

 

 

 


Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY

INDEX

 

         PAGE NO.  
PART I. FINANCIAL INFORMATION:   
Item 1.  

Financial Statements

  
 

Condensed, Consolidated Statements of Operations—Three and nine months ended July 2, 2011 and July 3, 2010

     3   
 

Condensed, Consolidated Statements of Cash Flows—Nine months ended July 2, 2011 and July 3, 2010

     4   
 

Condensed, Consolidated Balance Sheets—July 2, 2011, July 3, 2010 and September 30, 2010

     5   
 

Notes to Condensed, Consolidated Financial Statements

     6   
Item 2.  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     31   
Item 3.  

Quantitative and Qualitative Disclosures about Market Risk

     40   
Item 4.  

Controls and Procedures

     40   
PART II. OTHER INFORMATION:   
Item 1.  

Legal Proceedings

     40   
Item 1A.  

Risk Factors

     41   
Item 2.  

Unregistered Sales of Equity Securities and Use of Proceeds

     41   
Item 6.  

Exhibits

     42   
Signatures      43   
Index to Exhibits      44   

 

2


Table of Contents

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

THE SCOTTS MIRACLE-GRO COMPANY

CONDENSED, CONSOLIDATED STATEMENTS OF OPERATIONS

(IN MILLIONS, EXCEPT PER SHARE DATA)

(UNAUDITED)

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED      NINE MONTHS ENDED  
       JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Net sales

     $ 1,058.7       $ 1,172.6       $ 2,418.5       $ 2,475.7   

Cost of sales

       657.5         690.8         1,503.4         1,524.6   

Cost of sales—product registration and recall matters

       1.1         —           3.2         1.5   
    

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

       400.1         481.8         911.9         949.6   

Operating expenses:

             

Selling, general and administrative

       192.4         201.3         551.8         544.3   

Product registration and recall matters

       5.7         1.5         7.8         4.3   

Impairment, restructuring and other charges

       13.8         —           13.8         —     

Other income, net

       (4.2      (1.1      (5.0      (6.8
    

 

 

    

 

 

    

 

 

    

 

 

 

Income from operations

       192.4         280.1         343.5         407.8   

Costs related to refinancing

       1.2         —           1.2         —     

Interest expense

       14.0         11.2         37.3         35.0   
    

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations before income taxes

       177.2         268.9         305.0         372.8   

Income tax expense from continuing operations

       65.5         99.4         111.4         139.2   
    

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations

       111.7         169.5         193.6         233.6   

Income (loss) from discontinued operations, net of tax

       (0.1      6.4         27.7         3.1   
    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

     $ 111.6       $ 175.9       $ 221.3       $ 236.7   
    

 

 

    

 

 

    

 

 

    

 

 

 

BASIC INCOME PER COMMON SHARE:

             

Income from continuing operations

     $ 1.73       $ 2.55       $ 2.95       $ 3.53   

Income from discontinued operations

       —           0.10         0.42         0.05   
    

 

 

    

 

 

    

 

 

    

 

 

 

Basic net income per common share

     $ 1.73       $ 2.65       $ 3.37       $ 3.58   
    

 

 

    

 

 

    

 

 

    

 

 

 

Weighted-average common shares outstanding during the period

       64.5         66.5         65.6         66.2   
    

 

 

    

 

 

    

 

 

    

 

 

 

DILUTED INCOME PER COMMON SHARE:

             

Income from continuing operations

     $ 1.69       $ 2.50       $ 2.89       $ 3.46   

Income from discontinued operations

       —           0.09         0.41         0.05   
    

 

 

    

 

 

    

 

 

    

 

 

 

Diluted net income per common share

     $ 1.69       $ 2.59       $ 3.30       $ 3.51   
    

 

 

    

 

 

    

 

 

    

 

 

 

Weighted-average common shares outstanding during the period plus dilutive potential common shares

       66.2         67.9         67.1         67.4   
    

 

 

    

 

 

    

 

 

    

 

 

 

Dividends declared per common share

     $ 0.250       $ 0.125       $ 0.750       $ 0.375   
    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to condensed, consolidated financial statements

 

3


Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY

CONDENSED, CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN MILLIONS)

(UNAUDITED)

 

September 30, September 30,
       NINE MONTHS ENDED  
       JULY 2,
2011
     JULY 3,
2010
 

OPERATING ACTIVITIES

       

Net income

     $ 221.3       $ 236.7   

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

       

Impairment, restructuring and other charges, excluding share-based compensation expense

       12.4         —     

Costs related to refinancing

       1.2         —     

Share-based compensation expense

       14.3         12.5   

Depreciation

       37.3         36.3   

Amortization

       8.7         8.3   

Gain on sale of long-lived assets

       (0.1      (21.5

Gain on sale of business

       (93.0      —     

Changes in assets and liabilities, net of acquired businesses:

       

Accounts receivable

       (352.9      (311.3

Inventories

       (87.8      (13.9

Prepaid and other assets

       (8.0      (8.4

Accounts payable

       113.9         44.9   

Other current liabilities

       121.8         163.5   

Restructuring reserves

       (0.3      —     

Other non-current items

       (2.7      18.4   

Other, net

       0.4         (9.3
    

 

 

    

 

 

 

Net cash (used in) provided by operating activities

       (13.5      156.2   
    

 

 

    

 

 

 

INVESTING ACTIVITIES

       

Proceeds from sale of long-lived assets

       0.2         23.6   

Proceeds from sale of business, net of transaction costs

       253.9         —     

Investments in property, plant and equipment

       (53.3      (46.9

Payment of contingent consideration and related

       (20.0      —     

Investment in acquired business, net of cash acquired

       (0.8      —     
    

 

 

    

 

 

 

Net cash provided by (used in) investing activities

       180.0         (23.3

FINANCING ACTIVITIES

       

Borrowings under revolving and bank lines of credit and term loans

       1,419.2         927.8   

Repayments under revolving and bank lines of credit and term loans

       (1,459.2      (1,234.8

Proceeds from issuance of Senior Notes, net of discount

       200.0         198.5   

Financing and issuance fees

       (18.5      (5.5

Dividends paid

       (49.4      (25.9

Purchase of treasury shares

       (218.7      —     

Payments on seller notes

       —           (0.2

Excess tax benefits from share-based payment arrangements

       5.4         3.9   

Cash received from the exercise of stock options

       29.4         14.8   
    

 

 

    

 

 

 

Net cash used in financing activities

       (91.8      (121.4
    

 

 

    

 

 

 

Effect of exchange rate changes on cash

       1.5         (4.4
    

 

 

    

 

 

 

Net increase in cash and cash equivalents

       76.2         7.1   

Cash and cash equivalents at beginning of period

       88.1         70.6   
    

 

 

    

 

 

 

Cash and cash equivalents at end of period

     $ 164.3       $ 77.7   
    

 

 

    

 

 

 

Supplemental cash flow information

       

Interest paid, net of interest capitalized

     $ (33.6    $ (29.2

Income taxes paid

       (63.1      (39.0

See notes to condensed, consolidated financial statements

 

4


Table of Contents

THE SCOTTS MIRACLE-GRO COMPANY

CONDENSED, CONSOLIDATED BALANCE SHEETS

(IN MILLIONS, EXCEPT PER SHARE DATA)

 

September 30, September 30, September 30,
       JULY 2,
2011
     JULY 3,
2010
     SEPTEMBER 30,
2010
 
       UNAUDITED      (SEE NOTE 1)  

ASSETS

  

Current assets:

          

Cash and cash equivalents

     $ 164.3       $ 77.7       $ 88.1   

Accounts receivable, less allowances of $13.6, $7.3 and $7.7, respectively

       693.9         603.2         350.9   

Accounts receivable pledged

       —           23.3         —     

Inventories, net

       442.2         405.9         352.9   

Assets held for sale

       —           206.0         193.1   

Prepaid and other assets

       137.3         161.2         133.1   
    

 

 

    

 

 

    

 

 

 

Total current assets

       1,437.7         1,477.3         1,118.1   

Property, plant and equipment, net of accumulated depreciation of $496.8, $448.2 and $461.1, respectively

       394.3         359.4         381.3   

Goodwill

       306.5         305.8         305.8   

Intangible assets, net

       343.2         347.1         330.2   

Other assets

       45.5         33.6         28.6   
    

 

 

    

 

 

    

 

 

 

Total assets

     $ 2,527.2       $ 2,523.2       $ 2,164.0   
    

 

 

    

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

Current liabilities:

          

Current portion of debt

     $ 2.1       $ 200.0       $ 195.0   

Accounts payable

       258.8         213.3         141.7   

Liabilities held for sale

       —           44.4         45.3   

Other current liabilities

       490.2         536.4         354.8   
    

 

 

    

 

 

    

 

 

 

Total current liabilities

       751.1         994.1         736.8   

Long-term debt

       782.1         490.2         436.7   

Other liabilities

       225.7         204.1         226.0   
    

 

 

    

 

 

    

 

 

 

Total liabilities

       1,758.9         1,688.4         1,399.5   
    

 

 

    

 

 

    

 

 

 

Commitments and contingencies (notes 3 and 12)

          

Shareholders’ equity:

          

Common shares and capital in excess of $.01 stated value per share, 63.7, 66.9 and 66.8 shares issued and outstanding, respectively

       426.7         439.3         434.0   

Retained earnings

       671.3         548.8         499.6   

Treasury shares, at cost: 4.6, 1.6, and 1.8 shares, respectively

       (252.6      (86.5      (92.0

Accumulated other comprehensive loss

       (77.1      (66.8      (77.1
    

 

 

    

 

 

    

 

 

 

Total shareholders’ equity

       768.3         834.8         764.5   
    

 

 

    

 

 

    

 

 

 

Total liabilities and shareholders’ equity

     $ 2,527.2       $ 2,523.2       $ 2,164.0   
    

 

 

    

 

 

    

 

 

 

See notes to condensed, consolidated financial statements

 

5


Table of Contents

NOTES TO CONDENSED, CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF OPERATIONS

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of branded products for consumer lawn and garden care. The Company’s primary customers include home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers and food and drug stores. The Company’s products are sold primarily in North America and the European Union. The Company also operates the Scotts LawnService® business, which provides residential and commercial lawn care, tree and shrub care and limited pest control services in the United States.

On February 28, 2011, the Company completed the sale of a significant majority of the assets of its Global Professional business (excluding the non-European professional seed business, “Global Pro”) to Israel Chemicals Ltd. (“ICL”). Effective in the Company’s first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations. See “NOTE 2. DISCONTINUED OPERATONS.”

Due to the nature of the consumer lawn and garden business, the majority of sales to customers occur in the Company’s second and third fiscal quarters. On a combined basis, net sales for the second and third fiscal quarters represent approximately 75% of annual net sales.

ORGANIZATION AND BASIS OF PRESENTATION

The Company’s condensed, consolidated financial statements are unaudited; however, in the opinion of management, these financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The condensed, consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. Interim results reflect all normal and recurring adjustments and are not necessarily indicative of results for a full year.

Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with Scotts Miracle-Gro’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010, which includes a complete set of disclosures, including the Company’s significant accounting policies.

The Company’s Condensed, Consolidated Balance Sheet at September 30, 2010 has been derived from the Company’s audited Consolidated Balance Sheet at that date, but does not include all of the information and disclosures required by GAAP for complete financial statements.

USE OF ESTIMATES

The preparation of condensed, consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

RECENT ACCOUNTING PRONOUNCEMENTS

Variable Interest Entities

In June 2009, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance requiring an enterprise to perform an analysis to determine whether the enterprise’s variable interest or interests give it a controlling financial interest in a variable interest entity. The new guidance also requires enhanced disclosures that will provide users of financial statements with more transparent information about an enterprise’s involvement in a variable interest entity. The Company adopted the new guidance on October 1, 2010 and the adoption did not impact the Company’s financial statements and related disclosures.

 

6


Table of Contents

Revenue Recognition—Multiple-Element Arrangements

In October 2009, the FASB issued new accounting guidance addressing the accounting for multiple-deliverable arrangements to enable entities to account for products or services (deliverables) separately rather than as a combined unit. The provisions establish the accounting and reporting guidance for arrangements under which the entity will perform multiple revenue-generating activities. Specifically, this guidance addresses how to separate deliverables and how to measure and allocate arrangement consideration to one or more units of accounting. The Company adopted the new guidance on October 1, 2010 and the adoption did not impact the Company’s financial statements and related disclosures.

Fair Value Measurement

In May 2011, the FASB issued amended accounting guidance to improve comparability of fair value measures between GAAP and the International Financial Reporting Standards. The amended guidance clarifies how to apply the existing fair value measurement and disclosure requirements. The provisions will be effective for the Company’s financial statements beginning with the Company’s second quarter of fiscal 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

Comprehensive Income

In June 2011, the FASB issued amended accounting guidance on the presentation of comprehensive income. The amended guidance requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The provisions will be effective for the Company’s financial statements for the fiscal year beginning October 1, 2012. The Company is in the process of evaluating the impact that the amended guidance may have on its financial statements and related disclosures.

NOTE 2. DISCONTINUED OPERATIONS

Global Pro

On February 28, 2011, the Company completed the sale of Global Pro to ICL for $270 million, pursuant to the terms of the definitive share and business sale agreement (the “SBSA”) between Scotts Miracle-Gro, The Scotts Company LLC (“Scotts”), a wholly-owned subsidiary of Scotts Miracle-Gro, and ICL. After agreed upon adjustments (including post-closing adjustments), the Company received $270.9 million net proceeds. Results from discontinued operations for the first nine months of fiscal 2011 include an after-tax gain on the sale of Global Pro of $21.2 million, which includes transaction costs.

The Company’s decision to exit the professional ornamental horticulture, turf and specialty agriculture markets and sell Global Pro was another step in its strategy to evolve its business portfolio to better leverage growth opportunities within its core Global Consumer business segment. The Company applied a portion of the net proceeds of the sale toward debt retirement and intends to apply the remaining portion toward capital investments.

In conjunction with the transaction, Scotts and ICL entered into several product supply agreements which are generally up to five years in duration, as well as various trademark and technology licensing agreements with varying durations. The purpose of these agreements is to allow each party to continue leveraging existing production capabilities and intellectual property to meet customer demand for their respective products. Furthermore, certain transitional services are being provided by Scotts to ICL, the majority of which extend for a period of six to 12 months from the date of sale. Scotts estimates that it will supply ICL with approximately $35 million of product, as well as purchase approximately $15 million of materials from ICL, each on an annualized basis.

The Company’s continuing cash inflows and outflows related to these agreements are not considered to be significant in relation to the overall cash flows of Global Pro. Furthermore, none of these agreements permit the Company to influence the operating or financial policies of Global Pro under the ownership of ICL. Therefore, Global Pro met the criteria for presentation as discontinued operations. As such, effective in the first quarter of fiscal 2011, the Company classified Global Pro as discontinued operations for all periods presented.

The Global Pro results from discontinued operations include an allocation of interest expense relating to the amount of our senior secured credit facilities that was required to be repaid from the sale proceeds. The amount of interest expense allocated to and included in discontinued operations was $0.7 million for the three-month period ended July 3, 2010, and $1.7 million and $2.7 million for the nine-month periods ended July 2, 2011 and July 3, 2010, respectively.

Smith & Hawken Ltd.

In July 2009, Scotts Miracle-Gro announced that its wholly-owned subsidiary, Smith & Hawken, Ltd., had adopted a plan to close the Smith & Hawken+ business. During the Company’s first quarter of fiscal 2010, all Smith & Hawken stores were closed and substantially all operational activities of Smith & Hawken were discontinued. As a result, effective in its first quarter of fiscal 2010, the Company classified Smith & Hawken as discontinued operations.

 

+

Smith & Hawken® is a registered trademark of Target Brands, Inc. The Company sold the Smith & Hawken brand and certain intellectual property rights related thereto on December 30, 2009, and subsequently changed the name of the subsidiary entity formerly known as Smith & Hawken, Ltd. to Teak 2, Ltd. References in this Quarterly Report on Form 10-Q to Smith & Hawken refer to Scotts Miracle-Gro’s subsidiary entity, not the brand itself.

 

7


Table of Contents

In the first nine months of fiscal 2010, the Company incurred charges related to the liquidation of the Smith & Hawken business primarily associated with the termination of retail site lease obligations, third-party agency fees and severance and benefit commitments. These charges were partially offset by a gain of approximately $18 million from the sale of the Smith & Hawken intellectual property on December 30, 2009.

The following table summarizes the results of Global Pro and Smith & Hawken as discontinued operations (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED      NINE MONTHS ENDED  
       JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Net sales

     $ —         $ 66.3       $ 88.7       $ 203.3   

Operating costs

       —           56.2         78.1         190.9   

Impairment, restructuring and other charges

       —           0.4         —           19.3   

Gain on sale of Global Pro business

       (2.4      —           (93.0      —     

Global Pro sale related transaction costs

       2.2         —           17.0         —     

Other income, net

       (0.3      (0.6      (0.2      (19.1

Interest expense

       —           0.7         1.7         2.7   
    

 

 

    

 

 

    

 

 

    

 

 

 

Income from discontinued operations before income taxes

       0.5         9.6         85.1         9.5   

Income tax expense from discontinued operations

       0.6         3.2         57.4         6.4   
    

 

 

    

 

 

    

 

 

    

 

 

 

Income (loss) from discontinued operations

     $ (0.1    $ 6.4       $ 27.7       $ 3.1   
    

 

 

    

 

 

    

 

 

    

 

 

 

The major classes of assets and liabilities of Global Pro were as follows (in millions):

 

September 30, September 30,
       JULY 3,
2010
       SEPTEMBER 30,
2010
 

Cash and cash equivalents

     $ 1.0         $ 1.0   

Accounts receivable, net

       70.6           57.5   

Inventories, net

       55.7           50.7   

Prepaid and other assets

       2.4           3.4   

Property, plant and equipment, net

       13.2           13.5   

Goodwill

       63.1           67.0   
    

 

 

      

 

 

 

Assets held for sale

     $ 206.0         $ 193.1   
    

 

 

      

 

 

 

Accounts payable

     $ 16.2         $ 11.4   

Other current liabilities

       17.6           18.7   

Other liabilities

       10.6           15.2   
    

 

 

      

 

 

 

Liabilities held for sale

     $ 44.4         $ 45.3   
    

 

 

      

 

 

 

The major classes of assets and liabilities of Smith & Hawken were as follows (in millions):

 

September 30, September 30,
       JULY 3,
2010
       SEPTEMBER 30,
2010
 

Assets of discontinued operations in other current assets

     $ 5.2         $ 1.3   
    

 

 

      

 

 

 

Accounts payable

     $ 0.2         $ —     

Other current liabilities

       4.3           0.9   
    

 

 

      

 

 

 

Liabilities of discontinued operations

     $ 4.5         $ 0.9   
    

 

 

      

 

 

 

NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS

In April 2008, the Company became aware that a former associate apparently deliberately circumvented the Company’s policies and U.S. Environmental Protection Agency (“U.S. EPA”) regulations under the Federal Insecticide, Fungicide, and Rodenticide Act of 1947, as amended (“FIFRA”), by failing to obtain valid registrations for certain products and/or causing certain invalid product registration forms to be submitted to regulators. Since that time, the Company has been cooperating with both the U.S. EPA and the U.S. Department of Justice (the “U.S. DOJ”) in related civil and criminal investigations into the pesticide product registration issues as well as a state civil investigation into related allegations arising under state pesticide registration laws and regulations.

 

8


Table of Contents

In late April 2008, in connection with the U.S. EPA’s investigation, the Company conducted a consumer-level recall of certain consumer lawn and garden products and a Scotts LawnService® product. Subsequently, the Company and the U.S. EPA agreed upon a Compliance Review Plan for conducting a comprehensive, independent review of the Company’s product registration records. Pursuant to the Compliance Review Plan, an independent third-party firm, Quality Associates Incorporated (“QAI”), reviewed substantially all of the Company’s U.S. pesticide product registrations and associated advertisements, some of which were historical in nature and no longer related to sales of the Company’s products. The U.S. EPA investigation and the QAI review process resulted in the temporary suspension of sales and shipments of certain products. In addition, as the QAI review process or the Company’s internal review identified potential FIFRA registration issues (some of which appear unrelated to the actions of the former associate), the Company endeavored to stop selling or distributing the affected products until the issues could be resolved. QAI’s review of the Company’s U.S. pesticide product registrations and associated advertisements is now substantially complete. The results of the QAI review process did not materially affect the Company’s fiscal 2010 or year-to-date fiscal 2011 sales and are not expected to materially affect the Company’s sales during the remainder of fiscal 2011.

Settlement discussions relating to potential fines and/or penalties are a frequent outgrowth of governmental investigations. In that regard, on or about June 30, 2011, the Company received a Notice of Intent to File Administrative Complaint (“Notice”) from the U.S. EPA Region 5 with respect to the alleged FIFRA violations. The Notice, which does not set forth a proposed penalty amount, offers the Company an opportunity to present any information that it believes the U.S. EPA should consider prior to filing the complaint and indicates that the U.S. EPA is prepared to meet with the Company to discuss the alleged violations. The Company made a timely response to the Notice and communications between the Company and the U.S. EPA are underway. In addition, the Company recently began settlement discussions with the U.S. DOJ regarding its criminal investigation.

Based on the facts and circumstances known to the Company at this time (including settlement discussions that have taken place to date), the Company has established what it believes to be an appropriate reserve. The U.S. EPA and U.S. DOJ investigations continue, however, and may result in future state, federal or private rights of action including fines and/or penalties with respect to known or potential additional product registration issues. Until these investigations are completed, the Company cannot reasonably estimate the total scope or magnitude of all possible liabilities. It is possible that any such fines and/or penalties, as well as any judgments, litigation costs or other liabilities relating to such known or potential product registration issues, could exceed the amount of the reserve, possibly materially, and could have an adverse effect on the Company’s financial condition, results of operations or cash flows.

In June 2008, the California Department of Pesticide Regulation (“CDPR”) issued a request for information to the Company relating to products that had been the subject of the April 2008 recall. The Company cooperated with that inquiry and reached agreement with CDPR that CDPR would place its investigation on hold pending the completion of the Company’s internal audit. In furtherance of that agreement, in May 2010, the Company and CDPR executed a tolling agreement that extended CDPR’s rights through April 2012. In July 2010, CDPR notified the Company that CDPR planned to proceed with its investigation independent of the U.S. EPA and U.S. DOJ, and in March 2011, the Company received a letter from CDPR offering to settle the matter without the need for an enforcement proceeding for $245,631. On July 25, 2011, the Company paid the requested civil penalty and entered into a Settlement Agreement pursuant to which CDPR agreed not to take further civil or criminal action with regard to the affected products.

As a result of these registration and recall matters, the Company has recorded charges for affected inventory and other registration and recall-related costs. The effects of these adjustments, including the reserve noted above, were pre-tax charges of $6.8 million and $1.5 million for the three-month periods, and $11.0 million and $5.8 million for the nine-month periods ended July 2, 2011 and July 3, 2010, respectively. The Company expects that future charges will include costs associated with the rework of certain finished goods inventories, the potential disposal of certain products and ongoing third-party professional services related to the U.S. EPA, U.S. DOJ and state investigations. It may also be appropriate to establish additional reserves as settlement discussions continue.

The following tables summarize the impact of the product registration and recall matters on the Company’s results of operations during the three and nine months ended July 2, 2011 and July 3, 2010, and on accrued liabilities and inventory reserves as of July 2, 2011 (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED      NINE MONTHS ENDED  
       JULY 2, 2011      JULY 3, 2010      JULY 2, 2011      JULY 3, 2010  

Cost of sales—other charges

     $ 1.1       $ —         $ 3.2       $ 1.5   
    

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

       (1.1      —           (3.2      (1.5

Selling, general and administrative

       5.7         1.5         7.8         4.3   
    

 

 

    

 

 

    

 

 

    

 

 

 

Loss from operations

       (6.8      (1.5      (11.0      (5.8

Income tax benefit

       0.8         0.5         2.2         2.0   
    

 

 

    

 

 

    

 

 

    

 

 

 

Net loss

     $ (6.0    $ (1.0    $ (8.8    $ (3.8
    

 

 

    

 

 

    

 

 

    

 

 

 

 

9


Table of Contents
September 30, September 30, September 30, September 30,
       RESERVES AT
SEPTEMBER 30,
2010
       ADDITIONAL
COSTS AND
CHANGES IN
ESTIMATE
       RESERVES
USED
     RESERVES AT
JULY 2,
2011
 

Inventory reserves

     $ 3.0         $ 1.6         $ (0.6    $ 4.0   

Other incremental costs of sales

       0.5           1.6           (1.0      1.1   

Other general and administrative costs

       0.5           7.8           (3.4      4.9   
    

 

 

      

 

 

      

 

 

    

 

 

 

Accrued liabilities and inventory reserves

     $ 4.0         $ 11.0         $ (5.0    $ 10.4   
    

 

 

      

 

 

      

 

 

    

 

 

 

NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER CHARGES

During the three month period ended July 2, 2011, the Company recorded $13.8 million of impairment, restructuring and other charges relating to payments to the former owners of Turf-Seed, Inc. and severence related costs. On May 26, 2011, the Company and the former owners of Turf-Seed, Inc. agreed to an early settlement of the contingent consideration associated with Company’s fiscal 2006 acquisition of Turf-Seed, Inc. Concurrently, several other contracts and agreements between the Company and the former owners of Turf-Seed, Inc. were terminated or amended. The Company agreed to pay a total of $21.3 million to resolve these matters, resulting in a net charge of $10.3 million after consideration of previously recorded liabilities and other aspects of the agreements.

On August 8, 2011, the Company announced a restructuring plan designed to streamline management decision making, continue the regionalization of the Company’s operating structure and provide additional resources to invest in innovation and growth initiatives. During the three-month period ended July 2, 2011, the Company incurred $3.5 million in restructuring costs. The Company anticipates incurring total restructuring charges of $15-$20 million in fiscal 2011, primarily related to severence activities, to complete this restructuring initiative.

NOTE 5. DETAIL OF INVENTORIES, NET

Inventories, net of reserves for slow moving and obsolete inventories of $24.0 million, $28.2 million and $27.0 million as of July 2, 2011, July 3, 2010 and September 30, 2010, respectively, consisted of:

 

September 30, September 30, September 30,
       JULY 2,
2011
       JULY 3,
2010
       SEPTEMBER 30,
2010
 

Finished goods

     $ 258.7         $ 231.6         $ 144.8   

Work-in-process

       27.7           21.8           27.2   

Raw materials

       155.8           152.5           180.9   
    

 

 

      

 

 

      

 

 

 
     $ 442.2         $ 405.9         $ 352.9   
    

 

 

      

 

 

      

 

 

 

NOTE 6. MARKETING AGREEMENT

The Company is Monsanto’s exclusive agent for the marketing and distribution of consumer Roundup®* herbicide products (with additional rights to new products containing glyphosate or other similar non-selective herbicides) in the consumer lawn and garden market within the United States and other specified countries, including Australia, Austria, Belgium, Canada, France, Germany, the Netherlands and the United Kingdom. Under the terms of the Marketing Agreement, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The annual gross commission under the Marketing Agreement is calculated as a percentage of the actual earnings before interest and income taxes (EBIT) of the consumer Roundup® business in the markets covered by the Marketing Agreement and is based on the achievement of two earnings thresholds, as defined in the Marketing Agreement. The Marketing Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of the consumer Roundup® business. The annual contribution payment is defined in the Marketing Agreement as $20 million.

In consideration for the rights granted to the Company under the Marketing Agreement for North America, the Company was required to pay a marketing fee of $32 million to Monsanto. The Company has deferred this amount on the basis that the payment will provide a future benefit through commissions that will be earned under the Marketing Agreement. Based on management’s current assessment of the likely term of the Marketing Agreement, the useful life over which the marketing fee is being amortized is 20 years.

 

*

Roundup® is a registered trademark of Monsanto Technology LLC, a company affiliated with Monsanto Company (“Monsanto”).

 

10


Table of Contents

Under the terms of the Marketing Agreement, the Company performs certain functions, primarily manufacturing conversion, distribution and logistics, and selling and marketing support, on behalf of Monsanto in the conduct of the consumer Roundup® business. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred under the Marketing Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in “Cost of sales” and the reimbursement of these costs in “Net sales,” with no effect on gross profit or net income. The related net sales and cost of sales were $17.7 million and $18.9 million for the three-month periods, and $51.8 million and $54.0 million for the nine-month periods ended July 2, 2011 and July 3, 2010, respectively.

The elements of the net commission earned under the Marketing Agreement and included in “Net sales” are as follows (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED      NINE MONTHS ENDED  
       JULY 2, 2011      JULY 3, 2010      JULY 2, 2011      JULY 3, 2010  

Gross commission

     $ 32.9       $ 46.7       $ 65.9       $ 76.6   

Contribution expenses

       (5.0      (5.0      (15.0      (15.0

Amortization of marketing fee

       (0.2      (0.2      (0.6      (0.6
    

 

 

    

 

 

    

 

 

    

 

 

 

Net commission income

       27.7         41.5         50.3         61.0   

Reimbursements associated with Marketing Agreement

       17.7         18.9         51.8         54.0   
    

 

 

    

 

 

    

 

 

    

 

 

 

Total net sales associated with Marketing Agreement

     $ 45.4       $ 60.4       $ 102.1       $ 115.0   
    

 

 

    

 

 

    

 

 

    

 

 

 

The Marketing Agreement has no definite term except as it relates to the European Union countries (the “EU term”). The EU term extends through September 30, 2011, with up to two additional automatic renewal periods of two years each, subject to non-renewal only upon the occurrence of certain performance defaults. Thereafter, the Marketing Agreement provides that the parties may agree to renew the EU term for an additional three years.

The Marketing Agreement provides Monsanto with the right to terminate the Marketing Agreement upon an event of default (as defined in the Marketing Agreement) by the Company, a change in control of Monsanto or the sale of the consumer Roundup® business. The Marketing Agreement provides the Company with the right to terminate the Marketing Agreement in certain circumstances, including an event of default by Monsanto or the sale of the consumer Roundup® business. Unless Monsanto terminates the Marketing Agreement due to an event of default by the Company, Monsanto is required to pay a termination fee to the Company that varies by program year. The termination fee is calculated as a percentage of the value of the Roundup® business exceeding a certain threshold, but in no event will the termination fee be less than $16 million. If Monsanto were to terminate the Marketing Agreement due to an event of default by the Company, however, the Company would not be entitled to any termination fee, and the Company would lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Marketing Agreement provides. Monsanto may also be able to terminate the Marketing Agreement within a given region, including North America, without paying a termination fee if unit volume sales to consumers in that region decline: (1) over a cumulative three-fiscal-year period; or (2) by more than 5% for each of two consecutive years.

Under the Marketing Agreement, Monsanto must provide the Company with notice of any proposed sale of the consumer Roundup® business, allow the Company to participate in the sale process and negotiate in good faith with the Company with respect to any such proposed sale. In the event the Company acquires the consumer Roundup® business in such a sale, the Company would receive as a credit against the purchase price the amount of the termination fee that would have been paid to the Company if Monsanto had exercised its right to terminate the Marketing Agreement in connection with a sale to another party. If Monsanto decides to sell the consumer Roundup® business to another party, the Company must let Monsanto know whether the Company intends to terminate the Marketing Agreement and forfeit any right to a termination fee or whether it will agree to continue to perform under the Marketing Agreement on behalf of the purchaser.

NOTE 7. DEBT

The components of long-term debt are as follows (in millions):

 

September 30, September 30, September 30,
       JULY 2,
2011
       JULY 3,
2010
       SEPTEMBER 30,
2010
 

Credit Facilities:

              

Revolving loans

     $ 377.0         $ 108.8         $ 111.7   

Term loans

       —             344.4           302.4   

Senior Notes – 7.25%

       200.0           200.0           200.0   

Senior Notes – 6.625%

       200.0           —             —     

Master Accounts Receivable Purchase Agreement

       —             15.0           —     

Contingent consideration (see note 4)

       —             11.3           10.9   

Other

       7.2           10.7           6.7   
    

 

 

      

 

 

      

 

 

 
       784.2           690.2           631.7   

Less current portions

       2.1           200.0           195.0   
    

 

 

      

 

 

      

 

 

 
     $ 782.1         $ 490.2         $ 436.7   
    

 

 

      

 

 

      

 

 

 

 

11


Table of Contents

On June 30, 2011, Scotts Miracle-Gro and certain of its subsidiaries entered into a second amended and restated senior secured credit facility, providing for revolving loans in the aggregate principal amount of up to $1.7 billion over a five-year term. Borrowings may be made in various currencies including U.S. dollars, Euros, British pounds, Australian dollars and Canadian dollars. Under this amended and restated facility, the Company may request up to an additional $450 million in revolving and/or term commitments, subject to certain specified conditions, including approval from the Company’s lenders. The amended and restated facility replaces the Company’s previous senior secured credit facilities, which were comprised of: (a) a senior secured revolving loan facility in the aggregate principal of up to $1.59 billion and (b) a senior secured term loan facility totaling $560 million. The previous senior secured credit facilities were scheduled to expire in February 2012.

As of July 2, 2011, there was $1.3 billion of availability under the Company’s credit facility, including letters of credit. Under the facility, the Company has the ability to issue letter of credit commitments up to $75 million. At July 2, 2011, the Company had letters of credit in the aggregate face amount of $26.3 million outstanding.

On January 14, 2010, Scotts Miracle-Gro issued $200 million aggregate principal amount of 7.25% Senior Notes due 2018 (the “7.25% Senior Notes”). The net proceeds of the offering were used to reduce outstanding borrowings under the Company’s then existing senior secured credit facilities. The 7.25% Senior Notes represent general unsecured senior obligations of Scotts Miracle-Gro, and were sold to the public at 99.254% of the principal amount thereof, to yield 7.375% to maturity. The 7.25% Senior Notes have interest payment dates of January 15 and July 15 of each year, which began on July 15, 2010, and may be redeemed prior to maturity at applicable redemption premiums. The 7.25% Senior Notes contain usual and customary incurrence-based covenants, which include, but are not limited to, restrictions on the incurrence of additional indebtedness, the incurrence of liens and the issuance of certain preferred shares, and the making of certain distributions, investments and other restricted payments, as well as other usual and customary covenants, which include, but are not limited to, restrictions on sale and leaseback transactions, restrictions on purchases or redemptions of Scotts Miracle-Gro stock and prepayments of subordinated debt, limitations on asset sales and restrictions on transactions with affiliates. The 7.25% Senior Notes mature on January 15, 2018.

On December 16, 2010, Scotts Miracle-Gro issued $200 million aggregate principal amount of 6.625% Senior Notes due 2020 (the “6.625% Senior Notes”) in a private placement exempt from the registration requirements under the Securities Act of 1933, as amended. The net proceeds of the offering were used to repay outstanding borrowings under the Company’s then existing senior secured credit facilities and for general corporate purposes. The 6.625% Senior Notes represent general unsecured senior obligations of Scotts Miracle-Gro and rank equal in right of payment with the Company’s existing and future unsecured senior debt, including, without limitation, the 7.25% Senior Notes. The 6.625% Senior Notes have interest payment dates of June 15 and December 15 of each year, commencing June 15, 2011, and may be redeemed prior to maturity at applicable redemption premiums. The 6.625% Senior Notes contain usual and customary incurrence-based covenants, as well as other usual and customary covenants, substantially similar to those contained in the 7.25% Senior Notes. The 6.625% Senior Notes mature on December 15, 2020.

Certain of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of both the 7.25% and the 6.625% Senior Notes. Refer to “NOTE 16. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS” for more information regarding the guarantor entities.

The Company was in compliance with the terms of all borrowing agreements at July 2, 2011.

At July 2, 2011, the Company had outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of variable-rate debt denominated in U.S. dollars to a fixed rate. The swap agreements had a total U.S. dollar notional amount of $900 million at July 2, 2011. Interest payments made between the effective date and expiration date are hedged by the swap agreements, except as noted below. The notional amount, effective date, expiration date and rate of these swap agreements are shown in the table below.

 

September 30, September 30, September 30,

NOTIONAL AMOUNT

(IN MILLIONS)

  EFFECTIVE
DATE (a)
     EXPIRATION
DATE
     FIXED RATE
$ 200   2/14/2007      2/14/2012      5.20%
50   2/14/2012      2/14/2016      3.78%
150(b)   11/16/2009      5/16/2016      3.26%
50(c)   2/16/2010      5/16/2016      3.05%
150(b)   12/20/2011      6/20/2016      2.61%
150(c)   2/7/2012      5/7/2016      2.42%
100(c)   2/21/2012      5/23/2016      2.40%
50(d)   12/6/2012      9/6/2017      2.96%

 

12


Table of Contents
(a) The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

 

(b) Interest payments made during the six-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.

 

(c) Interest payments made during the three-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.

 

(d) Interest payments made during the nine-month period of each year that begins with the month and day of the effective date are hedged by the swap agreement.

Master Accounts Receivable Purchase Agreement

On May 1, 2009, the Company entered into a Master Accounts Receivable Purchase Agreement (the “2009 MARP Agreement”), with an initial stated termination date of May 1, 2010, or such later date as may be mutually agreed by the Company and its lender. The 2009 MARP Agreement provided for the discounted sale, on an uncommitted, revolving basis, of accounts receivable generated by a specified account debtor, with aggregate limits not to exceed $80 million. The 2009 MARP Agreement provided an interest rate that approximated the 7-day LIBOR rate plus 225 basis points.

On May 13, 2010, the Company and its lender entered into a First Amendment to the 2009 MARP Agreement (the “First Amendment”). The First Amendment, which was effective May 1, 2010, extended the stated termination date of the 2009 MARP Agreement through May 12, 2011, or such later date as may be mutually agreed by the Company and its lender. On May 10, 2011, the Company and its lender entered into a Second Amendment to the 2009 MARP Agreement which further extended the stated termination date through September 30, 2011, or such later date as may be mutually agreed by the Company and its lender.

The 2009 MARP Agreement, as amended by the First Amendment, provides an interest rate that approximates the 7-day LIBOR rate plus 125 basis points; the amendments did not otherwise modify any substantive provisions of the 2009 MARP Agreement.

The Company accounts for the sale of receivables under the 2009 MARP Agreement, as amended, as short-term debt and continues to carry the receivables on its Condensed, Consolidated Balance Sheet, primarily as a result of the Company’s right to repurchase receivables sold. The caption “Accounts receivable pledged” on the accompanying Condensed, Consolidated Balance Sheets in the amount of $23.3 million as of July 3, 2010 represents the pool of receivables that were designated as “sold” under the 2009 MARP Agreement, as amended, and served as collateral for short-term debt thereunder in the amount of $15.0 million as of July 3, 2010. There were no short-term borrowings under the amended 2009 MARP Agreement as of July 2, 2011 and September 30, 2010.

Estimated Fair Values

A description of the methods and assumptions used to estimate the fair values of the Company’s debt instruments is as follows:

Credit Facilities

The interest rate currently available to the Company fluctuates with the applicable LIBOR rate, prime rate or Federal Funds Effective Rate, and thus the carrying value is a reasonable estimate of fair value.

7.25% Senior Notes

The fair value of the 7.25% Senior Notes can be determined based on the trading of the 7.25% Senior Notes in the open market. The difference between the carrying value and the fair value of the 7.25% Senior Notes represents the premium or discount on that date. Based on the trading value on or around July 2, 2011, the fair value of the 7.25% Senior Notes was approximately $218.0 million.

6.625% Senior Notes

 

13


Table of Contents

The fair value of the 6.625% Senior Notes can be determined based on the trading of the 6.625% Senior Notes. The difference between the carrying value and the fair value of the 6.625% Senior Notes represents the premium or discount on that date. Based on the trading value on or around July 2, 2011, the fair value of the 6.625% Senior Notes was approximately $204.0 million.

Accounts Receivable Pledged

The interest rate on the short-term debt associated with accounts receivable pledged under the 2009 MARP Agreement fluctuates with the one-week LIBOR rate, and thus the carrying value is a reasonable estimate of fair value.

NOTE 8. COMPREHENSIVE INCOME

The components of other comprehensive income (expense) and total comprehensive income were as follows (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED      NINE MONTHS ENDED  
       JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Net income

     $ 111.6       $ 175.9       $ 221.3       $ 236.7   

Other comprehensive income (expense):

             

Change in valuation of derivative instruments

       (3.5      (3.8      4.6         5.1   

Pension and other postretirement related items

       1.0         (3.9      7.9         1.4   

Foreign currency translation adjustments

       (3.2      (5.3      (12.5      (0.4
    

 

 

    

 

 

    

 

 

    

 

 

 

Comprehensive income

     $ 105.9       $ 162.9       $ 221.3       $ 242.8   
    

 

 

    

 

 

    

 

 

    

 

 

 

NOTE 9. RETIREMENT AND RETIREE MEDICAL PLANS COST INFORMATION

The following summarizes the net periodic benefit cost from continuing operations for the various retirement and retiree medical plans sponsored by the Company (in millions):

 

September 30, September 30, September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED  
       JULY 2, 2011        JULY 3, 2010  
       U.S.
Pension
     International
Pension
     U.S.
Medical
       U.S.
Pension
     International
Pension
     U.S.
Medical
 

Components of net periodic benefit cost

                     

Service cost

     $ —         $ 0.4       $ 0.1         $ —         $ 0.5       $ 0.1   

Interest cost

       1.2         2.6         0.4           1.3         2.2         0.4   

Expected return on plan assets

       (1.3      (2.4      —             (1.2      (1.9      —     

Net amortization

       1.2         0.3         —             1.1         0.5         —     
    

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    

 

 

 

Net periodic benefit cost

     $ 1.1       $ 0.9       $ 0.5         $ 1.2       $ 1.3       $ 0.5   
    

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    

 

 

 

 

September 30, September 30, September 30, September 30, September 30, September 30,
       NINE MONTHS ENDED  
       JULY 2, 2011        JULY 3, 2010  
       U.S.
Pension
     International
Pension
     U.S.
Medical
       U.S.
Pension
     International
Pension
     U.S.
Medical
 

Components of net periodic benefit cost

                     

Service cost

     $ —         $ 1.2       $ 0.3         $ —         $ 1.5       $ 0.4   

Interest cost

       3.6         8.0         1.2           3.9         6.8         1.2   

Expected return on plan assets

       (3.9      (7.6      —             (3.8      (5.9      —     

Net amortization

       3.7         1.1         —             3.3         1.5         —     
    

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    

 

 

 

Net periodic benefit cost

     $ 3.4       $ 2.7       $ 1.5         $ 3.4       $ 3.9       $ 1.6   
    

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    

 

 

 

NOTE 10. SHARE-BASED COMPENSATION AWARDS

Share-Based Awards

The following is a summary of the share-based compensation awards granted during the periods indicated:

 

September 30, September 30,
       NINE MONTHS ENDED  
       JULY 2, 2011        JULY 3, 2010  

Options

       429,700           367,600   

Restricted stock units (including deferred stock units)

       95,570           287,508   

Performance shares

       —             4,200   

Performance units

       53,874           —     
    

 

 

      

 

 

 

Total share-based awards

       579,144           659,308   
    

 

 

      

 

 

 

Aggregate fair value at grant dates (in millions)

     $ 13.8         $ 16.9   

 

14


Table of Contents

Total share-based compensation recognized was as follows for the periods indicated (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS ENDED        NINE MONTHS ENDED  
       JULY 2, 2011           JULY 3, 2010           JULY 2, 2011           JULY 3, 2010   

Share-based compensation

     $  3.4         $ 4.3         $ 14.3         $ 12.5   

NOTE 11. INCOME TAXES

The effective tax rate related to continuing operations for the nine months ended July 2, 2011 was 36.5%, compared to 37.3% for the nine months ended July 3, 2010. The effective tax rate used for interim reporting purposes is based on management’s best estimate of factors impacting the effective tax rate for the full fiscal year. An allocation of the income tax expense has been separately determined to report the discontinued operations net of tax. There can be no assurance that the effective tax rate estimated for interim financial reporting purposes will approximate the effective tax rate determined at fiscal year end.

Scotts Miracle-Gro or one or more of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. With few exceptions, the Company is no longer subject to examinations by these tax authorities for fiscal years prior to 2008. The Company is currently under examination by the Internal Revenue Service (the “IRS”) and certain foreign and U.S. state and local tax authorities. The IRS is reviewing the fiscal 2008 tax period only. In regards to a local German audit, the tax periods under investigation are limited to fiscal years 2004 through 2008. In regards to U.S. state and local audits, the tax periods under investigation are limited to fiscal years 1997 through 2008. In addition to these audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company anticipates that few of its open and active audits will be resolved within the next 12 months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

NOTE 12. CONTINGENCIES

Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other fiduciary liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows. The following are the more significant of the Company’s identified contingencies:

FIFRA Compliance and the Corresponding Governmental Investigations

For a description of the Company’s ongoing FIFRA compliance efforts and the corresponding governmental investigations, see “NOTE 3. PRODUCT REGISTRATION AND RECALL MATTERS.”

Other Regulatory Matters

At July 2, 2011, $2.7 million was accrued for other regulatory matters in the “Other liabilities” line in the Condensed, Consolidated Balance Sheet. The amounts accrued are believed to be adequate to cover such known regulatory exposures based on current facts and estimates of likely outcomes. However, if facts and circumstances change significantly, they could result in a material adverse effect on the Company’s financial condition, results of operations or cash flows.

 

15


Table of Contents

Other

The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. The complaints in these cases are not specific about the plaintiffs’ contacts with the Company or its products. The Company in each case is one of numerous defendants and none of the claims seek damages from the Company alone. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no accrual or reserves have been recorded in the Company’s condensed, consolidated financial statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material adverse effect on the Company’s financial condition, results of operations or cash flows.

NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Derivatives and Hedging

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

The Company formally designates and documents qualifying instruments as hedges of underlying exposures at inception. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. GAAP requires all derivative instruments to be recognized as either assets or liabilities at fair value in the Condensed, Consolidated Balance Sheets. The Company designates commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Any ineffective portion of a change in the fair value of a qualifying instrument is immediately recognized in earnings. The amounts recorded in earnings related to ineffectiveness of derivative hedges for the three- and nine-month periods ended July 2, 2011 and July 3, 2010 were not significant.

Foreign Currency Swap Contracts

The Company periodically uses foreign currency swap contracts to manage the exchange rate risk associated with intercompany loans with foreign subsidiaries that are denominated in local currencies. At July 2, 2011 and July 3, 2010, the notional amount of outstanding foreign currency swap contracts was $382.4 million and $211.4 million, respectively, with a fair value of $0.8 million and a negative fair value of $5.6 million, respectively. The fair value of foreign currency swap contracts is determined based on changes in spot rates. The unrealized loss on the foreign currency swap contracts approximates the unrealized gain on the intercompany loans recognized by the Company’s lending subsidiaries.

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate exposure on debt instruments. The fair values are reflected in the Company’s Condensed, Consolidated Balance Sheets. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of accumulated other comprehensive loss (“AOCI”) within the Condensed, Consolidated Balance Sheets. The fair value of the swap agreements is determined based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date.

At July 2, 2011 and July 3, 2010, the Company had outstanding interest rate swap agreements with major financial institutions that effectively converted a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a total U.S. dollar equivalent notional amount of $900 million and $450 million at July 2, 2011 and July 3, 2010, respectively. Refer to “NOTE 7. DEBT” for the terms of the swap agreements outstanding at July 2, 2011. Included in the AOCI balance at July 2, 2011 was a pre-tax loss of $11.7 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

 

16


Table of Contents

Commodity Hedges

The Company had outstanding hedging arrangements at July 2, 2011 designed to fix the price of a portion of its projected future urea requirements. The contracts are designated as hedges of the Company’s exposure to future cash flow fluctuations associated with the cost of urea. The objective of the hedges is to mitigate the earnings and cash flow volatility attributable to the risk of changing prices. Unrealized gains or losses in the fair value of these contracts are recorded to the AOCI component of shareholders’ equity. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at July 2, 2011 was a pre-tax gain of $1.4 million related to urea derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

The Company enters into fuel derivatives for its Scotts LawnService® business that qualify for hedge accounting treatment. Unrealized gains or losses in the fair value of these contracts are recorded in other comprehensive income (expense), except for any ineffective portion of the change in fair value, which is immediately recorded in earnings. For the effective portion of the change in fair value, realized gains or losses remain as a component of AOCI until the related fuel is consumed by the Scotts LawnService® service vehicles. Upon consumption of the fuel, the gain or loss is reclassified to cost of sales. Included in the AOCI balance at July 2, 2011 was a pre-tax gain of $0.1 million related to fuel derivatives that is expected to be reclassified to earnings during the next 12 months, consistent with the timing of the underlying hedged transactions.

Periodically, the Company also uses fuel derivatives to partially mitigate the effect of fluctuating diesel and gasoline costs on operating results. Fuel derivatives used by the Company that do not qualify for hedge accounting treatment in accordance with GAAP are recorded at fair value, with unrealized gains and losses on open contracts and realized gains or losses on settled contracts recorded as an element of cost of sales.

As of July 2, 2011, the Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:

 

September 30,

Commodity

     Volume

Urea

     7,500 tons

Diesel

     1,344,000 gallons

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments were as follows (in millions):

 

    

ASSETS / (LIABILITIES)

 
     BALANCE SHEET    JULY 2,
2011
    JULY 3,
2010
    SEPTEMBER 30,
2010
 

DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS

  

LOCATION

   FAIR VALUE  

Interest rate swap agreements

   Other assets    $ 0.8      $ —        $ —     
   Other current liabilities      (13.0     —          (12.1
   Other liabilities      (4.6     (20.8     (12.5

Commodity hedging instruments

   Prepaid and other assets      0.6        —          1.9   
   Other current liabilities      —          (0.2     —     
     

 

 

   

 

 

   

 

 

 

Total derivatives designated as hedging instruments

      $ (16.2   $ (21.0   $ (22.7
     

 

 

   

 

 

   

 

 

 

DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS (1)

         

Foreign currency swap contracts

   Prepaid and other assets    $ 3.1      $ —        $ —     
   Other current liabilities      (2.3     (5.6     (6.6

Commodity hedging instruments

   Prepaid and other assets      0.3        —          —     
   Other current liabilities      —          (0.5     —     
     

 

 

   

 

 

   

 

 

 

Total derivatives not designated as hedging instruments (1)

      $ 1.1      $ (6.1   $ (6.6
     

 

 

   

 

 

   

 

 

 

Total derivatives

      $ (15.1   $ (27.1   $ (29.3
     

 

 

   

 

 

   

 

 

 

 

17


Table of Contents

 

(1) See discussion above for additional information regarding the Company’s purpose for entering into derivatives not designated as hedging instruments and its overall risk management strategy.

Refer to “NOTE 14. FAIR VALUE MEASUREMENTS” for the Company’s fair value measurements of derivative instruments as they relate to the valuation hierarchy.

The effect of derivative instruments on AOCI and the Condensed, Consolidated Statements of Operations for the three- and nine-month periods ended July 2, 2011 and July 3, 2010 was as follows:

 

September 30, September 30, September 30, September 30,

DERIVATIVES IN CASH FLOW HEDGING RELATIONSHIPS

     AMOUNT OF GAIN / (LOSS) RECOGNIZED IN AOCI
(IN MILLIONS)
 
     THREE MONTHS ENDED      NINE MONTHS ENDED  
     JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Interest rate swap agreements

     $ (6.4    $ (6.2    $ (5.1    $ (12.8

Commodity hedging instruments

       0.3         (0.6      1.7         1.5   
    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     $ (6.1    $ (6.8    $ (3.4    $ (11.3
    

 

 

    

 

 

    

 

 

    

 

 

 

 

September 30, September 30, September 30, September 30, September 30,

DERIVATIVES IN CASH FLOW

HEDGING RELATIONSHIPS

     LOCATION OF GAIN / (LOSS)
RECLASSIFIED FROM
AOCI INTO EARNINGS
       AMOUNT OF GAIN / (LOSS) RECLASSIFIED FROM AOCI INTO
EARNINGS (IN MILLIONS)
 
          THREE MONTHS ENDED      NINE MONTHS ENDED  
          JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Interest rate swap agreements

       Interest expense         $ (3.3    $ (3.2    $ (10.1    $ (14.7

Commodity hedging instruments

       Cost of sales           0.7         0.3         2.1         (2.5
         

 

 

    

 

 

    

 

 

    

 

 

 

Total

          $ (2.6    $ (2.9    $ (8.0    $ (17.2
         

 

 

    

 

 

    

 

 

    

 

 

 

DERIVATIVES NOT DESIGNATED AS

HEDGING INSTRUMENTS

     LOCATION OF GAIN  /
(LOSS)
RECOGNIZED IN
EARNINGS
       AMOUNT OF GAIN / (LOSS) RECOGNIZED IN EARNINGS
(IN MILLIONS)
 
          THREE MONTHS ENDED      NINE MONTHS ENDED  
          JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Foreign currency swap contracts

       Interest expense         $ 0.3       $ (5.6    $ 5.9       $ (4.9

Commodity hedging instruments

       Cost of sales           (0.3      (0.8      2.0         (0.9
         

 

 

    

 

 

    

 

 

    

 

 

 

Total

          $ —         $ (6.4    $ 7.9       $ (5.8
         

 

 

    

 

 

    

 

 

    

 

 

 

NOTE 14. FAIR VALUE MEASUREMENTS

GAAP defines fair value, establishes a framework for measuring fair value, and prescribes disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

 

18


Table of Contents

Derivatives

Derivatives consist of foreign currency, interest rate and commodity derivative instruments. For further information on the Company’s derivative instruments, refer to “NOTE 13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES.”

Other

Other financial assets consist of investment securities in non-qualified retirement plan assets. These securities are valued using observable market prices in active markets.

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at July 2, 2011 (in millions):

 

September 30, September 30, September 30, September 30,
       Quoted Prices in
Active Markets for
Identical Assets

(Level 1)
       Significant Other
Observable  Inputs
(Level 2)
     Unobservable
Inputs
(Level 3)
       Total  

Assets

                 

Derivatives

                 

Interest rate swap agreements

     $ —           $ 0.8       $ —           $ 0.8   

Foreign currency swap contracts

       —             3.1         —             3.1   

Commodity hedging instruments

       —             0.9         —             0.9   

Other

       7.5           —           —             7.5   
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ 7.5         $ 4.8       $ —           $ 12.3   
    

 

 

      

 

 

    

 

 

      

 

 

 

Liabilities

                 

Derivatives

                 

Interest rate swap agreements

     $ —           $ (17.6    $ —           $ (17.6

Foreign currency swap contracts

       —             (2.3      —             (2.3
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ —           $ (19.9    $ —           $ (19.9
    

 

 

      

 

 

    

 

 

      

 

 

 

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at July 3, 2010 (in millions):

 

September 30, September 30, September 30, September 30,
       Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
       Significant
Other
Observable
Inputs
(Level 2)
     Unobservable
Inputs
(Level 3)
       Total  

Assets

                 

Other

     $ 5.9         $ —         $ —           $ 5.9   
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ 5.9         $ —         $ —           $ 5.9   
    

 

 

      

 

 

    

 

 

      

 

 

 

Liabilities

                 

Derivatives

                 

Interest rate swap agreements

     $ —           $ (20.8    $ —           $ (20.8

Foreign currency swap contracts

       —             (5.6      —             (5.6

Commodity hedging instruments

       —             (0.7      —             (0.7
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ —           $ (27.1    $ —           $ (27.1
    

 

 

      

 

 

    

 

 

      

 

 

 

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis at September 30, 2010 (in millions):

 

19


Table of Contents
September 30, September 30, September 30, September 30,
       Quoted Prices in  Active
Markets for Identical
Assets
(Level 1)
       Significant Other
Observable  Inputs
(Level 2)
     Unobservable
Inputs
(Level 3)
       Total  

Assets

                 

Derivatives

                 

Commodity hedging instruments

     $ —           $ 1.9       $ —           $ 1.9   

Other

       6.5           —           —             6.5   
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ 6.5         $ 1.9       $ —           $ 8.4   
    

 

 

      

 

 

    

 

 

      

 

 

 

Liabilities

                 

Derivatives

                 

Interest rate swap agreements

     $ —           $ (24.6    $ —           $ (24.6

Foreign currency swap contracts

       —             (6.6      —             (6.6
    

 

 

      

 

 

    

 

 

      

 

 

 

Total

     $ —           $ (31.2    $ —           $ (31.2
    

 

 

      

 

 

    

 

 

      

 

 

 

NOTE 15. SEGMENT INFORMATION

The Company divides its business into the following segments—Global Consumer and Scotts LawnService®. This division of reportable segments is consistent with how the segments report to and are managed by senior management of the Company. Reclassifications have been made to prior period segment amounts to reflect changes in the allocation of certain shared expenses among the segments, which in management’s judgment better align those expenses with the associated drivers and benefits. Furthermore, the Company’s reportable segments have been revised to reflect the sale of a significant majority of its previously reported Global Professional business segment, which is now reported in discontinued operations. For additional information regarding the sale, refer to “NOTE 2. DISCONTINUED OPERATIONS.”

The Global Consumer segment consists of the U.S. Consumer and International Consumer business groups. The business groups comprising this segment manufacture, market and sell dry, granular slow-release lawn fertilizers, combination lawn fertilizer and control products, grass seed, spreaders, water-soluble, liquid and continuous release garden and indoor plant foods, plant care products, potting, garden and lawn soils, mulches and other growing media products, wild bird food, pesticide and rodenticide products. Products are marketed to mass merchandisers, home centers, large hardware chains, warehouse clubs, distributors, garden centers and grocers in the United States, Canada, Europe, Latin America and Australia.

The Scotts LawnService® segment provides lawn fertilization, disease and insect control and other related services such as core aeration, tree and shrub fertilization and limited pest control services primarily to residential consumers through Company-owned branches and franchises in the United States.

Segment performance is evaluated based on several factors, including income from continuing operations before amortization, product registration and recall costs, and impairment, restructuring and other charges, which is not a GAAP measure. Senior management of the Company uses this measure of operating profit to gauge segment performance because the Company believes this measure is the most indicative of performance trends and the overall earnings potential of each segment.

Corporate & Other consists of the Company’s non-European professional seed business and revenues and expenses associated with the Company’s supply agreements with ICL, as well as corporate and administrative expenses.

The following tables present segment financial information (in millions):

 

September 30, September 30, September 30, September 30,
       THREE MONTHS
ENDED
     NINE MONTHS
ENDED
 
       JULY 2,
2011
     JULY 3,
2010
     JULY 2,
2011
     JULY 3,
2010
 

Net sales:

             

Global Consumer

     $ 951.6       $ 1,085.9       $ 2,225.2       $ 2,314.6   

Scotts LawnService®

       82.4         81.3         152.2         144.9   
    

 

 

    

 

 

    

 

 

    

 

 

 

Segment total

       1,034.0         1,167.2         2,377.4         2,459.5   

Corporate & Other

       24.9         5.6         41.7         16.8   

Roundup® amortization

       (0.2      (0.2      (0.6      (0.6
    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     $ 1,058.7       $ 1,172.6       $ 2,418.5       $ 2,475.7   
    

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations before income taxes:

             

Global Consumer

     $ 209.9       $ 289.5       $ 453.8       $ 499.8   

Scotts LawnService®

       22.4         21.9         2.7         (0.7
    

 

 

    

 

 

    

 

 

    

 

 

 

Segment total

       232.3         311.4         456.5         499.1   

 

20


Table of Contents
September 30, September 30, September 30, September 30,

Corporate & Other

       (16.0      (27.3      (79.5      (77.4

Roundup® amortization

       (0.2      (0.2      (0.6      (0.6

Other amortization

       (3.1      (2.3      (8.1      (7.5

Product registration and recall matters

       (6.8      (1.5      (11.0      (5.8

Impairment, restructuring and other charges

       (13.8      —           (13.8      —     

Costs related to refinancing

       (1.2      —           (1.2      —     

Interest expense

       (14.0      (11.2      (37.3      (35.0
    

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated

     $ 177.2       $ 268.9       $ 305.0       $ 372.8   
    

 

 

    

 

 

    

 

 

    

 

 

 

 

September 30, September 30, September 30,
       JULY 2,
2011
       JULY 3,
2010
       SEPTEMBER 30,
2010
 

Total assets:

              

Global Consumer

     $ 2,037.9         $ 1,793.4         $ 1,458.4   

Scotts LawnService®

       180.2           177.5           177.7   

Corporate & Other

       309.1           346.3           334.8   

Assets held for sale

       —             206.0           193.1   
    

 

 

      

 

 

      

 

 

 

Consolidated

     $ 2,527.2         $ 2,523.2         $ 2,164.0   
    

 

 

      

 

 

      

 

 

 

Total assets reported for the Company’s operating segments include the intangible assets associated with the acquired businesses within those segments. Corporate & Other assets primarily include deferred financing and debt issuance costs, corporate intangible assets and deferred tax assets, and Smith & Hawken assets.

NOTE 16. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS

The 7.25% and 6.625% Senior Notes (collectively, the “Senior Notes”) issued by Scotts Miracle-Gro on January 14, 2010 and December 16, 2010, respectively, are guaranteed by certain of its domestic subsidiaries and, therefore, the Company has disclosed condensed, consolidating financial information in accordance with SEC Regulation S-X Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered. The following 100% directly or indirectly owned subsidiaries fully and unconditionally guarantee the Senior Notes on a joint and several basis: EG Systems, Inc., dba Scotts LawnService®; Gutwein & Co., Inc.; Hyponex Corporation; Miracle-Gro Lawn Products, Inc.; OMS Investments, Inc.; Rod McLellan Company; Sanford Scientific, Inc.; Scotts Temecula Operations, LLC; Scotts Manufacturing Company; Scotts Products Co.; Scotts Professional Products Co.; Scotts-Sierra Investments, Inc.; SMG Growing Media, Inc.; Swiss Farms Products, Inc.; and The Scotts Company LLC (collectively, the “Guarantors”).

The following information presents condensed, consolidating Statements of Operations for the three- and nine-month periods ended July 2, 2011 and July 3, 2010, condensed, consolidating Statements of Cash Flows for the nine-month periods ended July 2, 2011 and July 3, 2010, and condensed, consolidating Balance Sheets as of July 2, 2011, July 3, 2010 and September 30, 2010. The condensed, consolidating financial information presents, in separate columns, financial information for: Scotts Miracle-Gro on a Parent-only basis, carrying its investment in subsidiaries under the equity method; Guarantors on a combined basis, carrying their investments in subsidiaries which do not guarantee the debt (collectively, the “Non-Guarantors”) under the equity method; Non-Guarantors on a combined basis; and eliminating entries. The eliminating entries primarily reflect intercompany transactions, such as interest expense, accounts receivable and payable, short and long-term debt, and the elimination of equity investments and income in subsidiaries. Because Scotts Miracle-Gro, as the Parent, is obligated to pay the unpaid principal amount and interest on all amounts borrowed by the Guarantors or Non-Guarantors under the senior secured five-year revolving loan facility, the borrowings and related interest expense for the revolving loans outstanding of the Guarantors and Non-Guarantors are also presented in the accompanying Parent-only financial information, and are then eliminated.

 

21


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Operations

for the three months ended July 2, 2011

(in millions)

 

           Subsidiary     Non-              
     Parent     Guarantors     Guarantors     Eliminations     Consolidated  

Net sales

   $ —        $ 852.9      $ 205.8      $ —        $ 1,058.7   

Cost of sales

     —          528.8        128.7        —          657.5   

Cost of sales—product registration and recall matters

     —          1.1        —          —          1.1   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —          323.0        77.1        —          400.1   

Operating expenses:

          

Selling, general and administrative

     —          134.4        58.0        —          192.4   

Product registration and recall matters

     —          5.7        —          —          5.7   

Impairment, restructuring and other charges

     —          13.8        —          —          13.8   

Other income, net

     —          (4.2     —          —          (4.2
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     —          173.3        19.1        —          192.4   

Equity income in subsidiaries

     (120.3     (4.6     —          124.9        —     

Other non-operating income

     (5.4     —          —          5.4        —     

Costs related to refinancing

     1.2        —          —          —          1.2   

Interest expense

     13.1        5.3        1.0        (5.4     14.0   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     111.4        172.6        18.1        (124.9     177.2   

Income tax (benefit) expense from continuing operations

     (0.2     59.1        6.6        —          65.5   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     111.6        113.5        11.5        (124.9     111.7   

Income (loss) from discontinued operations, net of tax

     —          6.7        (6.8     —          (0.1
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 111.6      $ 120.2      $ 4.7      $ (124.9   $ 111.6   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

22


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Operations

for the nine months ended July 2, 2011

(in millions)

 

           Subsidiary     Non-              
     Parent     Guarantors     Guarantors     Eliminations     Consolidated  

Net sales

   $ —        $ 1,961.1      $ 457.4      $ —        $ 2,418.5   

Cost of sales

     —          1,208.5        294.9        —          1,503.4   

Cost of sales—product registration and recall matters

     —          3.2        —          —          3.2   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —          749.4        162.5        —          911.9   

Operating expenses:

          

Selling, general and administrative

     —          421.1        130.7        —          551.8   

Product registration and recall matters

     —          7.8        —          —          7.8   

Impairment, restructuring and other charges

     —          13.8        —          —          13.8   

Other income, net

     —          (3.9     (1.1     —          (5.0
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     —          310.6        32.9        —          343.5   

Equity income in subsidiaries

     (242.5     (5.2     —          247.7        —     

Other non-operating income

     (15.0     —          —          15.0        —     

Costs related to refinancing

     1.2        —          —          —          1.2   

Interest expense

     35.6        14.4        2.3        (15.0     37.3   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations before income taxes

     220.7        301.4        30.6        (247.7     305.0   

Income tax (benefit) expense from continuing operations

     (0.6     100.8        11.2        —          111.4   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income from continuing operations

     221.3        200.6        19.4        (247.7     193.6   

Income (loss) from discontinued operations, net of tax

     —          41.8        (14.1     —          27.7   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 221.3      $ 242.4      $ 5.3      $ (247.7   $ 221.3   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

23


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Cash Flows

for the nine months ended July 2, 2011

(in millions)

 

           Subsidiary     Non-               
     Parent     Guarantors     Guarantors     Eliminations      Consolidated  

NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES

   $ (16.0   $ 54.1      $ (51.6   $ —         $ (13.5
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

INVESTING ACTIVITIES

           

Proceeds from sale of long-lived assets

     —          0.2        —          —           0.2   

Proceeds from sale of business, net of transaction costs

     —          159.0        94.9        —           253.9   

Investments in property, plant and equipment

     —          (49.7     (3.6     —           (53.3

Payment of contingent consideration

     —          (20.0     —          —           (20.0

Investments in acquired business, net of cash acquired

     —          (0.8     —          —           (0.8
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by investing activities

     —          88.7        91.3        —           180.0   

FINANCING ACTIVITIES

           

Borrowings under revolving and bank lines of credit and term loans

     —          860.5        558.7        —           1,419.2   

Repayments under revolving and bank lines of credit and term loans

     (302.4     (494.6     (662.2     —           (1,459.2

Proceeds from issuance of Senior Notes

     200.0        —               200.0   

Financing and issuance fees

     (18.5     —          —          —           (18.5

Dividends paid

     (49.4     —          —          —           (49.4

Purchase of treasury shares

     (218.7     —          —          —           (218.7

Excess tax benefits from share-based payment arrangements

     —          5.4        —          —           5.4   

Cash received from exercise of stock options

     29.4        —          —          —           29.4   

Intercompany financing

     375.6        (499.7     124.1        —           —     
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net cash provided by (used in) financing activities

     16.0        (128.4     20.6        —           (91.8
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Effect of exchange rate changes on cash

     —          —          1.5        —           1.5   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Net increase in cash and cash equivalents

     —          14.4        61.8        —           76.2   

Cash and cash equivalents, beginning of period

     —          5.0        83.1        —           88.1   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Cash and cash equivalents, end of period

   $ —        $ 19.4      $ 144.9      $ —         $ 164.3   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

24


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Balance Sheet

As of July 2, 2011

(in millions)

 

            Subsidiary      Non-              
     Parent      Guarantors      Guarantors     Eliminations     Consolidated  

ASSETS

  

Current assets:

            

Cash and cash equivalents

   $ —         $ 19.4       $ 144.9      $ —        $ 164.3   

Accounts receivable, net

     —           500.4         193.5        —          693.9   

Inventories, net

     —           362.8         79.4        —          442.2   

Prepaid and other current assets

     —           93.7         43.6        —          137.3   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total current assets

     —           976.3         461.4        —          1,437.7   

Property, plant and equipment, net

     —           347.1         47.2        —          394.3   

Goodwill

     —           305.8         0.7        —          306.5   

Intangible assets, net

     —           288.6         54.6        —          343.2   

Other assets

     28.1         21.7         43.3        (47.6     45.5   

Equity investment in subsidiaries

     936.1         —           —          (936.1     —     

Intercompany assets

     599.9         235.2         —          (835.1     —     
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total assets

   $ 1,564.1       $ 2,174.7       $ 607.2      $ (1,818.8   $ 2,527.2   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

Current liabilities:

            

Current portion of debt

   $ —         $ 2.1       $ —        $ —        $ 2.1   

Accounts payable

     —           185.5         73.3        —          258.8   

Other current liabilities

     18.8         335.2         136.2        —          490.2   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total current liabilities

     18.8         522.8         209.5        —          751.1   

Long-term debt

     777.0         380.1         2.0        (377.0     782.1   

Other liabilities

     0.0         209.9         63.4        (47.6     225.7   

Equity investment in subsidiaries

     —           223.3         —          (223.3     —     

Intercompany liabilities

     —           —           458.1        (458.1     —     
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total liabilities

     795.8         1,336.1         733.0        (1,106.0     1,758.9   

Shareholders’ equity

     768.3         838.6         (125.8     (712.8     768.3   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 1,564.1       $ 2,174.7       $ 607.2      $ (1,818.8   $ 2,527.2   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

 

25


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Operations

for the three months ended July 3, 2010

(in millions)

 

           Subsidiary     Non-               
     Parent     Guarantors     Guarantors      Eliminations     Consolidated  

Net sales

   $ —        $ 1,005.3      $ 167.3       $ —        $ 1,172.6   

Cost of sales

     —          581.5        109.3         —          690.8   

Cost of sales—product registration and recall matters

     —          —          —           —          —     
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Gross profit

     —          423.8        58.0         —          481.8   

Operating expenses:

           

Selling, general and administrative

     —          180.0        21.3         —          201.3   

Product registration and recall matters

     —          1.5        —           —          1.5   

Other (income) expense, net

     —          (1.2     0.1         —          (1.1
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Income from operations

     —          243.5        36.6         —          280.1   

Equity income in subsidiaries

     (180.1     (28.3     —           208.4        —     

Other non-operating income

     (5.3     —          —           5.3        —     

Interest expense

     9.7        5.4        1.4         (5.3     11.2   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Income from continuing operations before income taxes

     175.7        266.4        35.2         (208.4     268.9   

Income tax (benefit) expense from continuing operations

     (0.2     86.6        13.0         —          99.4   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Income from continuing operations

     175.9        179.8        22.2         (208.4     169.5   

Income from discontinued operations, net of tax

     —          —          6.4         —          6.4   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

Net income

   $ 175.9      $ 179.8      $ 28.6       $ (208.4   $ 175.9   
  

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

 

26


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Operations

for the nine months ended July 3, 2010

(in millions)

 

September 30, September 30, September 30, September 30, September 30,
              Subsidiary      Non-                
       Parent      Guarantors      Guarantors      Eliminations      Consolidated  

Net sales

     $ —         $ 2,073.8       $ 401.9       $ —         $ 2,475.7   

Cost of sales

       —           1,259.2         265.4         —           1,524.6   

Cost of sales—product registration and recall matters

       —           1.5         —           —           1.5   
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

       —           813.1         136.5         —           949.6   

Operating expenses:

                

Selling, general and administrative

       —           454.5         89.8         —           544.3   

Product registration and recall matters

       —           4.3         —           —           4.3   

Other income, net

       —           (4.8      (2.0      —           (6.8
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Income from operations

       —           359.1         48.7         —           407.8   

Equity income in subsidiaries

       (245.2      (30.6      —           275.8         —     

Other non-operating income

       (21.3      —           —           21.3         —     

Interest expense

       30.5         21.4         4.4         (21.3      35.0   
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations before income taxes

       236.0         368.3         44.3         (275.8      372.8   

Income tax (benefit) expense from continuing operations

       (0.7      123.4         16.5         —           139.2   
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Income from continuing operations

       236.7         244.9         27.8         (275.8      233.6   

Income from discontinued operations, net of tax

       —           —           3.1         —           3.1   
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

     $ 236.7       $ 244.9       $ 30.9       $ (275.8    $ 236.7   
    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

27


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Statement of Cash Flows

for the nine months ended July 3, 2010

(in millions)

 

September 30, September 30, September 30, September 30, September 30,
              Subsidiary      Non-                  
       Parent      Guarantors      Guarantors      Eliminations        Consolidated  

NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES

     $ (38.0    $ 184.1       $ 10.1       $ —           $ 156.2   
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

INVESTING ACTIVITIES

                  

Proceeds from sale of long-lived assets

       —           23.6         —           —             23.6   

Investments in property, plant and equipment

       —           (44.4      (2.5      —             (46.9
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

Net cash used in investing activities

       —           (20.8      (2.5      —             (23.3

FINANCING ACTIVITIES

                  

Borrowings under revolving and bank lines of credit and term loans

       —           593.1         334.7         —             927.8   

Repayments under revolving and bank lines of credit and term loans

       —           798.4         (436.4      —             (1,234.8

Proceeds from issuance of Senior Notes, net of discount

       198.5                    198.5   

Financing and issuance fees

       (5.5      —           —           —             (5.5

Dividends paid

       (25.9      —           —           —             (25.9

Payments on seller notes

       —           (0.2      —           —             (0.2

Excess tax benefits from share-based payment arrangements

       —           3.9         —           —             3.9   

Cash received from exercise of stock options

       14.8         —           —           —             14.8   

Intercompany financing

       (143.9      37.4         106.5         —             —     
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

Net cash provided by (used in) financing activities

       38.0         (164.2      4.8         —             (121.4
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

Effect of exchange rate changes on cash

       —           —           (4.4      —             (4.4
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

Net (decrease) increase in cash and cash equivalents

       —           (0.9      8.0         —             7.1   

Cash and cash equivalents, beginning of period

       —           6.4         64.2         —             70.6   
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

Cash and cash equivalents, end of period

     $ —         $ 5.5       $ 72.2       $ —           $ 77.7   
    

 

 

    

 

 

    

 

 

    

 

 

      

 

 

 

 

28


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Balance Sheet

As of July 3, 2010

(in millions)

 

            Subsidiary      Non-               
     Parent      Guarantors      Guarantors      Eliminations     Consolidated  

ASSETS

  

Current assets:

             

Cash and cash equivalents

   $ —         $ 5.5       $ 72.2       $ —        $ 77.7   

Accounts receivable, net

     —           442.0         161.2         —          603.2   

Accounts receivable pledged

     —           23.3         —           —          23.3   

Inventories, net

     —           339.8         66.1         —          405.9   

Assets held for sale

     —           —           206.0         —          206.0   

Prepaid and other current assets

     —           113.7         47.5         —          161.2   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total current assets

     —           924.3         553.0         —          1,477.3   

Property, plant and equipment, net

     —           315.5         43.9         —          359.4   

Goodwill

     —           305.1         0.7         —          305.8   

Intangible assets, net

     —           294.8         52.3         —          347.1   

Other assets

     15.4         19.6         40.5         (41.9     33.6   

Equity investment in subsidiaries

     1,001.5         —           —           (1,001.5     —     

Intercompany assets

     376.6         —           —           (376.6     —     
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total assets

   $ 1,393.5       $ 1,859.3       $ 690.4       $ (1,420.0   $ 2,523.2   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

Current liabilities:

             

Current portion of debt

   $ 180.6       $ 16.9       $ 2.5       $ —        $ 200.0   

Accounts payable

     —           148.4         64.9         —          213.3   

Liabilities held for sale

     —           —           44.4         —          44.4   

Other current liabilities

     7.2         395.4         133.8         —          536.4   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total current liabilities

     187.8         560.7         245.6         —          994.1   

Long-term debt

     367.0         20.8         105.6         (3.2     490.2   

Other liabilities

     3.9         185.8         56.3         (41.9     204.1   

Equity investment in subsidiaries

     —           92.6         —           (92.6     —     

Intercompany liabilities

     —           96.1         277.3         (373.4     —     
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities

     558.7         956.0         684.8         (511.1     1,688.4   

Shareholders’ equity

     834.8         903.3         5.6         (908.9     834.8   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 1,393.5       $ 1,859.3       $ 690.4       $ (1,420.0   $ 2,523.2   
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

 

 

29


Table of Contents

The Scotts Miracle-Gro Company

Condensed, Consolidating Balance Sheet

As of September 30, 2010

(in millions)

 

            Subsidiary      Non-               
     Parent      Guarantors      Guarantors      Eliminations     Consolidated  

ASSETS

  

Current assets:

             

Cash and cash equivalents

   $ —         $ 5.0       $ 83.1       $ —        $ 88.1   

Accounts receivable, net

     —           265.5         85.4         —          350.9   

Inventories, net

     —           287.7         65.2         —          352.9   

Assets held for sale

     —